PMID- 15640349 OWN - NLM STAT- MEDLINE DCOM- 20050315 LR - 20190816 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 102 IP - 3 DP - 2005 Jan 18 TI - Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. PG - 749-54 AB - Mutations in the MEN1 gene are associated with the multiple endocrine neoplasia syndrome type 1 (MEN1), which is characterized by parathyroid hyperplasia and tumors of the pituitary and pancreatic islets. The mechanism by which MEN1 acts as a tumor suppressor is unclear. We have recently shown that menin, the MEN1 protein product, interacts with mixed lineage leukemia (MLL) family proteins in a histone methyltransferase complex including Ash2, Rbbp5, and WDR5. Here, we show that menin directly regulates expression of the cyclin-dependent kinase inhibitors p27Kip1 and p18Ink4c. Menin activates transcription by means of a mechanism involving recruitment of MLL to the p27Kip1 and p18Ink4c promoters and coding regions. Loss of function of either MLL or menin results in down-regulation of p27Kip1 and p18Ink4c expression and deregulated cell growth. These findings suggest that regulation of cyclin-dependent kinase inhibitor transcription by cooperative interaction between menin and MLL plays a central role in menin's activity as a tumor suppressor. FAU - Milne, Thomas A AU - Milne TA AD - Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. FAU - Hughes, Christina M AU - Hughes CM FAU - Lloyd, Ricardo AU - Lloyd R FAU - Yang, Zhaohai AU - Yang Z FAU - Rozenblatt-Rosen, Orit AU - Rozenblatt-Rosen O FAU - Dou, Yali AU - Dou Y FAU - Schnepp, Robert W AU - Schnepp RW FAU - Krankel, Cynthia AU - Krankel C FAU - Livolsi, Virginia A AU - Livolsi VA FAU - Gibbs, Denise AU - Gibbs D FAU - Hua, Xianxin AU - Hua X FAU - Roeder, Robert G AU - Roeder RG FAU - Meyerson, Matthew AU - Meyerson M FAU - Hess, Jay L AU - Hess JL LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20050107 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (CDKN1B protein, human) RN - 0 (CDKN2C protein, human) RN - 0 (Carrier Proteins) RN - 0 (Cell Cycle Proteins) RN - 0 (Cyclin-Dependent Kinase Inhibitor p18) RN - 0 (DNA-Binding Proteins) RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (KMT2A protein, human) RN - 0 (MEN1 protein, human) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Transcription Factors) RN - 0 (Tumor Suppressor Proteins) RN - 147604-94-2 (Cyclin-Dependent Kinase Inhibitor p27) RN - 149025-06-9 (Myeloid-Lymphoid Leukemia Protein) RN - EC 2.1.1.43 (Histone-Lysine N-Methyltransferase) RN - EC 2.7.11.22 (Cyclin-Dependent Kinases) SB - IM MH - Carrier Proteins/genetics MH - Cell Cycle Proteins/genetics MH - Cell Line MH - Cell Proliferation MH - Cyclin-Dependent Kinase Inhibitor p18 MH - Cyclin-Dependent Kinase Inhibitor p27 MH - Cyclin-Dependent Kinases/*antagonists & inhibitors MH - DNA-Binding Proteins/genetics/*physiology MH - *Gene Expression Regulation MH - Histone-Lysine N-Methyltransferase MH - Humans MH - Intracellular Signaling Peptides and Proteins/genetics MH - Myeloid-Lymphoid Leukemia Protein MH - Open Reading Frames MH - Promoter Regions, Genetic MH - Proto-Oncogene Proteins/*physiology MH - Proto-Oncogenes/genetics/*physiology MH - Transcription Factors/genetics/*physiology MH - Transcriptional Activation MH - Transfection MH - Tumor Suppressor Proteins/genetics PMC - PMC545577 EDAT- 2005/01/11 09:00 MHDA- 2005/03/16 09:00 PMCR- 2005/07/18 CRDT- 2005/01/11 09:00 PHST- 2005/01/11 09:00 [pubmed] PHST- 2005/03/16 09:00 [medline] PHST- 2005/01/11 09:00 [entrez] PHST- 2005/07/18 00:00 [pmc-release] AID - 0408836102 [pii] AID - 01020749 [pii] AID - 10.1073/pnas.0408836102 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):749-54. doi: 10.1073/pnas.0408836102. Epub 2005 Jan 7.